Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders

E. Jost, N. do Ó, E. Dahl, C. E. Maintz, P. Jousten, L. Habets, S. Wilop, J. G. Herman, R. Osieka, O. Galm

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Fingerprint

Dive into the research topics of 'Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders'. Together they form a unique fingerprint.

Medicine & Life Sciences